JONATHAN HATTON: Open Payments
NPI 1629362397 · WHITESBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$352 in 16 payments from 8 companies in 2025. Trend: 2023 $830 · 2024 $702 · 2025 $352
Food & beverage: $352
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 7 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 1 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: SUBLOCADE, CAPLYTA, AIRSUPRA, JOURNAVX, HETLIOZ, Kerendia, ZERBAXA, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
